SIM
JAZZ icon

Sonora Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sonora Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1102
2021
Q2 		$0 Buy
+2
New +$346 ﹤0.01% 1032
2020
Q3 		– Sell
-29
Closed -$3K – 1831
2020
Q2 		$3K Buy
+29
New +$3.21K ﹤0.01% 1515

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Sonora Investment Management's JAZZ Position: Q3 2021 in Review

Sonora Investment Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2021 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Sonora Investment Management first reported a position in JAZZ in Q2 2020 and has held it in 3 quarters since. The position peaked at $3K in Q2 2020. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Sonora Investment Management held 2 shares of Jazz Pharmaceuticals worth $0 as of Q3 2021.
  • Sonora Investment Management left its Jazz Pharmaceuticals share count unchanged in Q3 2021.
  • Jazz Pharmaceuticals made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1102 holding.
  • Sonora Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • Sonora Investment Management's Jazz Pharmaceuticals position peaked at $3K in Q2 2020.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.